Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

33.3%

5 terminated/withdrawn out of 15 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

27%

4 trials in Phase 3/4

Results Transparency

70%

7 of 10 completed trials have results

Key Signals

7 with results

Enrollment Performance

Analytics

Phase 2

9(60.0%)

Phase 3

3(20.0%)

Phase 4

1(6.7%)

Phase 1

1(6.7%)

N/A

1(6.7%)

15Total

Phase 2(9)

Phase 3(3)

Phase 4(1)

Phase 1(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (15)

Showing 15 of 15 trials

NCT04088721Phase 1Completed

Tolerability and Potential Efficacy of AD17002 in Subjects With Allergic Rhinitis

Role: collaborator

NCT00291525Not ApplicableCompleted

Randomized On-X Anticoagulation Trial

Role: collaborator

NCT04652518Phase 2Terminated

LYT-100 in Post-acute COVID-19 Respiratory Disease

Role: collaborator

NCT04241315Phase 3Completed

ELUCIDATE: Enabling Lung Cancer Identification Using Folate Receptor Targeting

Role: collaborator

NCT04334460Phase 2Completed

Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects

Role: collaborator

NCT03151408Phase 3Terminated

An Efficacy and Safety Study Of Pracinostat In Combination With Azacitidine In Adults With Acute Myeloid Leukemia

Role: collaborator

NCT01336530Phase 3Terminated

Tepilta® Versus Oxetacaine, Antacids and Placebo

Role: collaborator

NCT04531592Phase 2Withdrawn

Valproic Acid (VPA) for Acute Kidney Injury (AKI) in Liver Transplant Patients

Role: collaborator

NCT04531579Phase 2Withdrawn

Valproic Acid (VPA) for Acute Kidney Injury (AKI) in Trauma Patients

Role: collaborator

NCT03113825Phase 2Completed

Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery

Role: collaborator

NCT02966028Phase 2Completed

Effect of SNF472 on Progression of Cardiovascular Calcification in End-Stage-Renal-Disease (ESRD) Patients on Hemodialysis (HD)

Role: collaborator

NCT01660633Phase 2Completed

Safety & Efficacy Study High Dose Evomela Injection for MA Conditioning in MM Patients With Autologous Transplantation

Role: collaborator

NCT02037555Phase 2Completed

Safety and Efficacy of Preoperative Antithrombin Supplementation in Patients Undergoing High-Risk Cardiopulmonary Bypass

Role: collaborator

NCT02151643Phase 2Completed

Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease

Role: collaborator

NCT02596048Phase 4Completed

A Multicenter Study of Iomeron®-400 Used With Multi-detector Computed Tomography Angiography (MDCTA)

Role: collaborator

All 15 trials loaded